• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSF1800015 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2018-10-29 赛真(北京)生物技术有限公司 SciGen (Beijing) Biotechnology Co Ltd Certificate Issued 2018-11-20 view
JYSF2000005 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-02-21 赛真(北京)生物技术有限公司 SciGen (Beijing) Biotechnology Co Ltd Certificate Issued 2020-03-06 view
JYSB1700082 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2017-04-27 Lilly France Lilly France In Review 2017-04-26 view
JYSZ1900060 重组人胰岛素注射液 human insulin Injection Biological Products License Renew 2019-11-21 Lilly France Lilly France Certificate Issued 2020-05-21 view
CYSB0600108 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2007-03-12 通化东宝药业股份有限公司 Tonghua Dongbao Pharmaceutical Co Ltd Certificate Issued 2008-01-29 view
JYSZ1800013 重组人胰岛素注射液 human insulin Injection Biological Products License Renew 2018-05-17 赛真(北京)生物技术有限公司 SciGen (Beijing) Biotechnology Co Ltd Certificate Issued 2018-09-12 view
JYSB2000042 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-02-14 赛真(北京)生物技术有限公司 SciGen (Beijing) Biotechnology Co Ltd Filed 2020-02-20 view
JYSB1900174 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2019-07-18 Lilly France Lilly France Certificate Issued 2019-11-01 view
JYSB1800071 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2018-04-17 赛真(北京)生物技术有限公司 SciGen (Beijing) Biotechnology Co Ltd Filed 2018-05-09 view
JYSB1200154 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2012-06-19 Lilly France Lilly France Approval Completed-Pending Certificated 2014-12-29 view
JYSB2000472 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-09-27 Lilly France Lilly France Filed 2020-10-19 view
JYSB1600049 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2016-04-05 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2016-08-03 view
JXSS0700055 重组人胰岛素注射液 human insulin Injection Biological Products(7) Import Drug Application 2007-12-10 合肥生命科技园投资开发有限公司 Hefei Life Science & Technology Park Investments & Development Co Ltd Certificate Issued 2008-12-08 view
AS19990014 重组人胰岛素注射液 human insulin Injection Biological Products Import Drug Application 2000-01-01 赫司特(中国)投资有限公司 Approval Completed-Pending Certificated view
CYSB2000247 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-10-30 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2021-08-06 view
JYSZ1200090 重组人胰岛素注射液 human insulin Injection Biological Products License Renew 2012-12-24 Lilly France Lilly France Certificate Issued 2013-12-17 view
JYSB2000503 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-10-13 Lilly France Lilly France Certificate Issued 2020-11-26 view
JYSB1700081 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2017-05-03 Lilly France Lilly France In Review 2017-04-29 view
JXSL1200024 重组人胰岛素注射液 human insulin Injection Biological Products Import Drug Application 2012-04-09 杭州泰格医药科技股份有限公司 Hangzhou Tigermed Consulting Co Ltd Certificate Issued 2014-06-17 view
JYSB2000258 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-19 view